Activation of Akt by lithium: Pro-survival pathways in aging
Authors:
- Marc Yeste-VelascoMYMarc Yeste-Velasco
- Xiongwei ZhuXZXiongwei Zhu
- Steven P. ChouSCSteven P. Chou
- Mark A. SmithMSMark A. Smith
- Mercè PallàsMercè Pallàs
- Antoni CaminsAntoni Camins
- Gemma CasadesúsGCGemma Casadesús
- 1 April 2009
- journal article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 130 (4) , 253-261
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysisBritish Journal of Pharmacology, 2008
- Lithium delays progression of amyotrophic lateral sclerosisProceedings of the National Academy of Sciences, 2008
- Pharmacogenetic Analysis of Lithium-induced Delayed Aging in Caenorhabditis elegansJournal of Biological Chemistry, 2008
- Glycogen synthase kinase-3 is involved in the regulation of the cell cycle in cerebellar granule cellsNeuropharmacology, 2007
- Lithium Reduces Tau Phosphorylation but Not Aβ or Working Memory Deficits in a Transgenic Model with Both Plaques and TanglesThe American Journal of Pathology, 2007
- Chronic administration of melatonin reduces cerebral injury biomarkers in SAMP8Journal of Pineal Research, 2007
- Hyperphosphorylation of microtubule-associated protein tau in senescence-accelerated mouse (SAM)Mechanisms of Ageing and Development, 2005
- IGF-1 receptor regulates lifespan and resistance to oxidative stress in miceNature, 2002
- The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s DiseaseNeurosignals, 2002
- Lithium blocks the PKB and GSK3 dephosphorylation induced by ceramide through protein phosphatase-2ACellular Signalling, 2002